ASSETS AND LIABILITIES HELD FOR SALE	3 Months Ended
ASSETS AND LIABILITIES HELD FOR SALE	Mar. 31, 2026
ASSETS AND LIABILITIES HELD FOR SALE [Abstract]
ASSETS AND LIABILITIES HELD FOR SALE	5. ASSETS AND LIABILITIES HELD FOR SALE In the first quarter of 2026, the Company completed the sale of its plasma collection centers located in Maryville, Tennessee (“Maryville Center”), Knoxville, Tennessee (“Knoxville Center”), and Laurel, Maryland (“Laurel Center” and, collectively with the Maryville Center and Knoxville Center, the “Disposal Group”), in that order. The sale was completed pursuant to an Asset Purchase Agreement entered into on December 31, 2025, which provided for an aggregate purchase price of $12.0 million, with fifty percent (50%) of the consideration in the form of one-year secured promissory notes bearing interest at ten percent (10%) and the remaining fifty percent (50%) payable in cash, $1.0 million of which was received in December 2025. As a result of the sale of the Disposal Group, the Company recognized a gain of approximately $8.0 million. We have recorded the one-year secured promissory notes within prepaid expenses and other current assets and recognized the gain within Gain on sale of plasma centers.

ADMA BIOLOGICS, INC. 10-Q